Investing in people
Lux Capital invests in emerging science and technology ventures at the outermost edges of what is possible.
We partner with iconoclastic inventors challenging the status quo and the laws of nature to bring their futuristic ideas to life.
Play Video Discover LUXOur Companies
Want to know what the future will look like? Spend some time with our companies. You might meet a genetic engineer programming matter at the molecular level; a biologist and electrical engineer designing a new surgical robot; an astrophysicist launching rockets into space; or a materials scientist making circuits using a technique lifted from once-classified government programs.
-
Auris HealthAuris Health is an ambitious robotics company based in Silicon Valley. Auris was acquired by Johnson & Johnson in 2019.
-
CTRL-labs
CTRL-labs is changing the way we interact with computers. CTRL-labs was acquired by Facebook in 2019.
-
Desktop Metal
Desktop Metal is bringing high-speed, high-performance, 3D metal printing to the office environment.
-
Drone Racing League
Drone Racing League is a sports, media and technology company that combines world-class pilots, iconic locations, and proprietary technology to create engaging drone races with mass appeal.
-
Matterport
Matterport is the world’s most powerful all-in-one 3D data platform lets you turn a space into an accurate and immersive digital twin.
-
Recursion Pharmaceuticals
Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets.
-
Saildrone
Saildrone collects valuable ocean data using a fleet of unmanned, autonomous sailing drones.
-
Zoox
Zoox is what comes after the automobile.
Our team is willing to take a chance on something other investors do not see.
We are neuroscientists, chemists, data scientists, computational biologists, economists, electrical engineers, machine-learning hackers and philosophers. We get fired up when audacious experimentation leads to heresy and reinvention.
News & Insights
VIDEO: Avail Medsystems CEO Daniel Hawkins explains how telemedicine can be used in the operating room
Yahoo Finance-
May 28, 2020
Biotech R&D Software Startup Benchling, Started By MIT Undergrads, Scores $850 Million Valuation Amid Coronavirus Pandemic
-
May 28, 2020
Our Investment In Benchling
-
May 28, 2020
Biotech Startup Aims to Make Use of Humanity’s Genetic Outliers
-
May 28, 2020
An Invitation: The Most Outlier Humans
-
May 26, 2020
Meet the 26 healthcare startups that top VCs say are poised to take off amid the coronavirus pandemic